Edurant (Rilpivirine, TMC278)
| Brand Name: |
Edurant |
| Generic Name: |
Rilpivirine |
| Adult Single Dose: |
One 25-mg tablet taken once a day |
| Food & Liquid Restrictions: |
Take with meal |
| Drug Class: |
NNRTI |
|
|
|
The Basics
- Patient Information About Edurant (Rilpivirine) Tablets (PDF) (December 2012)
From Janssen Pharmaceuticals, Inc.
- An Overview of Edurant (Rilpivirine) (December 11, 2012)
From AIDSinfo
- Rilpivirine (Edurant) (December 11, 2012)
To read PDF, click here.
From AIDS InfoNet
- Edurant (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 DHHS Adult and Adolescent Antiretroviral Treatment Guidelines Panel Releases Supplemental Information Regarding the Role of Rilpivirine as Initial Therapy (August 16, 2011)
To read PDF, click here.
From AIDSinfo
 Edurant (Rilpivirine): The HIV Treatment Dating Game Just Got More Interesting (May 26, 2011)
An interview with Cal Cohen, M.D.
From TheBody.com
News & Research
- Labeling Updates for Edurant (Rilpivirine) (January 3, 2013)
From U.S. Food and Drug Administration
- Switching to Rilpivirine/Tenofovir/FTC Fixed-Dose Combination From Boosted-PI Regimen: SPIRIT Study Draws the Line at 24 Weeks (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Early Data for Rilpivirine Long-Acting Formulation Supports Further Investigation for PrEP (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Studies on Pipeline Antiretrovirals Reveal New Data on Possible Drug Interactions (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Similar Efficacy and a Few Gender-Related Differences in Side Effects With Rilpivirine Versus Efavirenz at 96 Weeks (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Conference Update From IAS 2011: Medication News (September/October 2011)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approve New NNRTI Rilpivirine (Edurant) in the U.S. (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Edurant and Sustiva Similar, With Some Failure and Safety Differences, in Two-Year Studies (July 21, 2011)
From AIDSmeds.com
- A New HIV Drug Called Edurant Gets Approved for First-Time Patients (May 20, 2011)
From Project Inform
- FDA Approves Edurant (Rilpivirine) for Use in Treatment-Naive Adults With HIV-1 (May 20, 2011)
From Tibotec Therapeutics
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
